PAP

Persistent Asset Partners Portfolio holdings

AUM $114M
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$113M
AUM Growth
-$3.41M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
181
New
Increased
Reduced
Closed

Top Buys

1
+$7.55M
2
+$7.05M
3
+$4.43M
4
LLY icon
Eli Lilly
LLY
+$2.49M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$2.49M

Top Sells

1
+$9.26M
2
+$4.96M
3
+$3.51M
4
CAH icon
Cardinal Health
CAH
+$2.63M
5
DFS
Discover Financial Services
DFS
+$1.87M

Sector Composition

1 Healthcare 63.66%
2 Financials 21.94%
3 Materials 3.92%
4 Energy 1.87%
5 Industrials 0.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LXRX icon
151
Lexicon Pharmaceuticals
LXRX
$516M
– –
0
MNKD icon
152
MannKind Corp
MNKD
$1.68B
– –
0
MRK icon
153
Merck
MRK
$212B
– –
-13,422
MRNA icon
154
Moderna
MRNA
$10.2B
– –
0
NKTR icon
155
Nektar Therapeutics
NKTR
$1.1B
– –
-11,105
NUVL icon
156
Nuvalent
NUVL
$6.67B
– –
-4,435
OCUL icon
157
Ocular Therapeutix
OCUL
$2.51B
– –
0
ORIC icon
158
Oric Pharmaceuticals
ORIC
$1.24B
– –
-7,373
OSBC icon
159
Old Second Bancorp
OSBC
$899M
– –
-68,343
PFE icon
160
Pfizer
PFE
$139B
– –
-13,530
RARE icon
161
Ultragenyx Pharmaceutical
RARE
$3.14B
– –
0
RCUS icon
162
Arcus Biosciences
RCUS
$1.75B
– –
-50,213
RKT icon
163
Rocket Companies
RKT
$46.9B
– –
-12,426
RXRX icon
164
Recursion Pharmaceuticals
RXRX
$2.56B
– –
0
SAVA icon
165
Cassava Sciences
SAVA
$208M
– –
0
SMMT icon
166
Summit Therapeutics
SMMT
$15.6B
– –
0
SOFI icon
167
SoFi Technologies
SOFI
$31.8B
– –
-64,600
SPY icon
168
SPDR S&P 500 ETF Trust
SPY
$660B
– –
0
SYF icon
169
Synchrony
SYF
$25.8B
– –
-6,214
TARS icon
170
Tarsus Pharmaceuticals
TARS
$3.08B
– –
-15,477
TOWN icon
171
Towne Bank
TOWN
$2.66B
– –
-12,426
UBX
172
DELISTED
Unity Biotechnology
UBX
– –
0
VBNK
173
VersaBank
VBNK
$385M
– –
-34,178
VERV
174
DELISTED
Verve Therapeutics
VERV
– –
0
VIR icon
175
Vir Biotechnology
VIR
$803M
– –
-24,069
4 5 6
7
8